According to primary research conducted by FMI’s healthcare domain, the global Surface Plasmon Resonance (SPR) System Market is expected to grow steadily, reaching a valuation of USD 1.0 billion by 2024. This positive momentum is projected to continue, with the market forecasted to escalate to USD 1.6 billion by 2034, marking a compound annual growth rate (CAGR) of 5.1%.
Driving Factors for Market Growth
The increasing adoption of SPR technology in drug discovery, biomolecular interaction analysis, and diagnostics is propelling market growth. The technique’s ability to deliver precise, label-free real-time analysis of molecular interactions has made it indispensable for research laboratories and pharmaceutical industries.
Key Takeaways
- Market Valuation in 2024: USD 1.0 billion.
- Market Valuation in 2034: USD 1.6 billion.
- CAGR: 5.1% from 2024 to 2034.
- Growth Drivers: Rising demand for drug discovery tools, biomolecular interaction studies, and advancements in SPR technology.
Regional Insights
- North America: Dominates the market due to robust R&D activities, advanced healthcare infrastructure, and high adoption of SPR technology.
- Europe: Follows closely, with strong investments in life sciences research and widespread use of SPR systems in academic and pharmaceutical research.
- Asia-Pacific: Anticipated to witness the fastest growth, driven by increasing research investments, expanding pharmaceutical industries, and improving healthcare infrastructure.
- Latin America & Middle East/Africa: Emerging regions with potential growth, driven by rising awareness and adoption of advanced diagnostic technologies.
Competitive Landscape
The surface plasmon resonance system market is characterized by the presence of several established players and emerging companies offering a diverse range of instrumentation, consumables, as well as services.
Company Portfolio
- Biacore, a division of GE Healthcare, specializes in providing advanced surface plasmon resonance systems for label free biomolecular interaction analysis. Their portfolio includes a range of instruments such as the Biacore T200 and Biacore 8K, equipped with high sensitivity, throughput, and automation capabilities.
- Bio-Rad Laboratories offers a comprehensive portfolio of surface plasmon resonance systems under its ProteOn™ and ProteOn XPR36™ platforms. The systems enable real time, label free analysis of biomolecular interactions, protein kinetics, and small molecule binding studies.
Key Companies Profiled
- Biacore (acquired by GE Healthcare)
- Bio-Rad Laboratories
- Attana AB
- Nicoya
- BioNavis Ltd.
- Reichert Technologies
- Biosensing Instrument Inc.
- GWC Technologies Inc.
- Plexera Bioscience LLC
- Horiba Scientific
- Sensata Technologies
- Carterra Inc.
- AMETEK Advanced Motion Solutions
- Genoptix (a Novartis company)
- BiOptix Diagnostics (acquired by ForteBio)
- Insplorion AB
- SPR Therapeutics
- Ssens BV
- Kinetic Biosystems
- Sierra Sensors GmbH
Get Complete Full Report
Segmentation Analysis of the Surface Plasmon Resonance System Market
By Product:
- Imaging System
- Sensor System
- Reagents
By Application:
- Drug Discovery
- Material Science
- Biosensors
By End User:
- Academic and Research Institutes
- Food and Beverage Industry
- Biopharmaceutical Companies
- CROs
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- The Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube